Arab Health Exhibition & Congress: Kibion’s new instrument meets the needs of laboratories, hospitals and doctor’s offices for rapid and reliable diagnosis of Helicobacter pylori infections

Kibion’s new instrument Kibion® Dynamic for 13C-labelled stable isotopes based on infra-red technology is currently being launched in several countries. Kibion® Dynamic offers a complete integrated system with a user-friendly large touch screen. The instrument can be up-scaled by using an innovative extension device – Kibion® Dynamic Pro – for increased throughput based on the needs of the laboratory, hospital or doctor’s office.

Kibion® Dynamic, together with the fast-dissolving tablet Diabact®UBT, offers a unique combination and technology platform for detection of the stomach ulcer bacterium Helicobacter pylori infections.

“The state-of-the-art Kibion® Dynamic instrument has been developed based on our leading knowledge and expertise in this area. We have also brought in novel and innovative ideas by active listening and learning from our customers who we recognize as the true experts with the best insight into what the features and benefits are that bring value into the everyday operational use of the instrument,” said Petter Backgren, CEO, Kibion.

Gulf Drug Establishment, Kibion’s exclusive distributor in the Gulf Region will present the new Kibion instrument’s features and benefits at the Arab Health event, January 25-28 in Dubai.

Kibion estimates that the overall market for Urea Breath Tests will grow and a key driver will be the increased interest from the pharma industry as several new treatment options for Helicobacter pylori infections are under development. This indicates that there is still an unmet medical need for improved treatments and consequently also for rapid and reliable diagnosis.

To gain an even greater presence in the market providing laboratories, hospitals and clinics with complete solutions for rapid reliable Urea Breath Tests, Kibion is constantly seeking new opportunities and collaborations to further strengthen its global leading position.

Kibion® Dynamic

The Arab Health Exhibition & Congress is the largest healthcare exhibition and medical congress in the Middle East and the second largest in the world. Gulf Drug LLC, Hall 2, Stand 2D30.

Petter Backgren, CEO, Kibion AB, + 46 (0)70 555 6997, email hidden; JavaScript is required

About Kibion
Kibion is a diagnostic company and a world-leading supplier of breath tests and analytical instruments for diagnosing the gastric ulcer bacterium Helicobacter pylori. The products Kibion® Dynamic, Heliprobe® System and Diabact® UBT are sold in more than 60 countries with the Middle East and the EU being the largest markets. Kibion is headquartered in Uppsala, Sweden, with a subsidiary, Kibion GmbH, in Bremen, Germany.